Mody K - Search Results

1

Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival.

Botrus G, Uson Junior PLS, Raman P, Kaufman AE, Kosiorek H, Yin J, Fu Y, Majeed U, Sonbol MB, Ahn DH, Chang IW, Drusbosky LM, Dada H, Starr J, Borad M, Mody K, Bekaii-Saab TS. Botrus G, et al. Among authors: mody k. Front Oncol. 2022 Jan 10;11:794009. doi: 10.3389/fonc.2021.794009. eCollection 2021. Front Oncol. 2022. PMID: 35083150 Free PMC article.

2

The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.

Elias AW, Kasi PM, Stauffer JA, Thiel DD, Colibaseanu DT, Mody K, Joseph RW, Bagaria SP. Elias AW, et al. Among authors: mody k. Front Oncol. 2017 Jun 12;7:121. doi: 10.3389/fonc.2017.00121. eCollection 2017. Front Oncol. 2017. PMID: 28660171 Free PMC article.

3

Clinical Trials and Progress in Metastatic Colon Cancer.

Mody K, Bekaii-Saab T. Mody K, et al. Surg Oncol Clin N Am. 2018 Apr;27(2):349-365. doi: 10.1016/j.soc.2017.11.008. Surg Oncol Clin N Am. 2018. PMID: 29496094 Review.

4

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies.

Mody K, Cleary SP. Mody K, et al. Front Oncol. 2018 Jun 11;8:212. doi: 10.3389/fonc.2018.00212. eCollection 2018. Front Oncol. 2018. PMID: 29942792 Free PMC article. Review.

5

Antiangiogenic Therapy in Colorectal Cancer.

Mody K, Baldeo C, Bekaii-Saab T. Mody K, et al. Cancer J. 2018 Jul/Aug;24(4):165-170. doi: 10.1097/PPO.0000000000000328. Cancer J. 2018. PMID: 30119079 Review.

6

A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors.

Mody K, Mansfield AS, Vemireddy L, Nygren P, Gulbo J, Borad M. Mody K, et al. Invest New Drugs. 2019 Aug;37(4):684-692. doi: 10.1007/s10637-018-0703-9. Epub 2018 Nov 21. Invest New Drugs. 2019. PMID: 30460505 Clinical Trial.

7

A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine/cisplatin.

Mody K, Antwi SO, Hodge DO, Ailawadhi S, Roberts L, Bekaii-Saab T. Mody K, et al. J Gastrointest Oncol. 2018 Dec;9(6):1063-1073. doi: 10.21037/jgo.2018.07.09. J Gastrointest Oncol. 2018. PMID: 30603125 Free PMC article.

8

A Care Process Model to Deliver ¹⁷⁷Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors.

Kasi PM, Maige CL, Shahjehan F, Rodgers JM, Aloszka DL, Ritter A, Andrus ML, Mcmillan JM, Mody K, Sharma A, Jain MK. Kasi PM, et al. Among authors: mody k. Front Oncol. 2019 Jan 9;8:663. doi: 10.3389/fonc.2018.00663. eCollection 2018. Front Oncol. 2019. PMID: 30687638 Free PMC article.

9

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer.

Sonbol MB, Benkhadra R, Wang Z, Firwana B, Walden DJ, Mody K, Hubbard JM, Murad MH, Ahn DH, Bekaii-Saab T. Sonbol MB, et al. Among authors: mody k. Oncologist. 2019 Sep;24(9):1174-1179. doi: 10.1634/theoncologist.2019-0189. Epub 2019 Jun 4. Oncologist. 2019. PMID: 31164455 Free PMC article.

10

Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas.

Iqbal M, Roberts A, Starr J, Mody K, Kasi PM. Iqbal M, et al. Among authors: mody k. J Gastrointest Oncol. 2019 Jun;10(3):400-406. doi: 10.21037/jgo.2019.01.14. J Gastrointest Oncol. 2019. PMID: 31183188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters